External Beam Radiation, Internal Brachytherapy, and Systemic Radiation Solutions
Radiation oncology encompasses several distinct treatment modalities categorized by how radiation doses are delivered to targeted anatomical structures. These technologies are tailored based on tumor location, stage, histology, and patient health status.
The industry is structured into three primary therapeutic categories:
-
External Beam Radiation Therapy (EBRT): Represents the largest segment of clinical practice. EBRT utilizes medical linear accelerators (LINACs) to direct high-energy X-ray or electron beams at tumors from outside the body. Advanced sub-modalities include Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), and Stereotactic Body Radiation Therapy (SBRT).
-
Internal Radiation Therapy (Brachytherapy): Involves placing sealed radioactive sources (seeds, ribbons, or capsules) directly inside or adjacent to cancerous tissue using specialized catheters or applicators. This delivers high radiation doses locally while sparing surrounding organs.
-
Systemic Radiotherapy: Utilizes radioisotopes administered intravenously or orally to target specific cancer cells throughout the body, such as targeted radionuclide therapies for thyroid or metastatic prostate cancers.
+------------------------------------+-------------------------------------------+----------------------------------------+
| Modality Category | Underlying Technology | Primary Clinical Applications |
+------------------------------------+-------------------------------------------+----------------------------------------+
| External Beam Radiation (EBRT) | Linear Accelerators (LINAC), CyberKnife | Breast, lung, prostate, brain tumors |
| Internal Brachytherapy | Radioactive seeds, HDR/LDR applicators | Gynecological, prostate, head & neck |
| Systemic Radiotherapy | Unsealed radioisotopes, radiopharmaceuticals| Thyroid cancer, metastatic bone lesions|
| Particle / Proton Beam Therapy | Cyclotrons, synchrotrons | Pediatric cancers, spinal/skull tumors |
+------------------------------------+-------------------------------------------+----------------------------------------+
Integrating artificial intelligence (AI) and machine learning algorithms into treatment planning software allows radiation oncologists to auto-contour organs at risk and adapt radiation doses in real time. Organizations evaluating equipment categories, technological roadmaps, and capital expenditure trends can explore deep-dive insights within the detailed Radiotherapy Market study.
Explore additional reports to understand evolving market landscapes:
Diabetic Nephropathy Market Trends
